Table 1

Patient demographics and characteristics of each event

Index eventFirst recurrent eventSecond recurrent eventThird recurrent event
CHD
Patients, n97 32121 90256011731
Male, n (%)66 690(68.5)
Age, years, median (Q1–Q3)65(56–77)
Length of stay, days
 Median (Q1–Q3)4(2–6)3(2–7)4(2–8)5(2–9)
Time from last event to the current event, days
 Median (Q1–Q3)NA213(56–500)176(55–384)124(43–303)
Follow-up, months
 Median (Q1–Q3)36(36–36)24(11–33)16(6–26)13(5–21)
CBVD
Patients, n120 91425 33766442153
Male, n (%)71 934(59.5)
Age, years, median (Q1–Q3)71(61–80)
Length of stay, days
 Median (Q1–Q3)7(4–13)8(4–19)9(5–23)11(5–26)
Time from last event to the current event, days
 Median (Q1–Q3)NA162(30–502)99(34–306)72(35–210)
Follow-up, months
 Median (Q1–Q3)36(33–36)24(10–34)19(8–30)18(7–29)
PAD
Patients, n14 794595124631073
Male, n (%)8534(57.7)
Age, years, median (Q1–Q3)74(63–82)
Length of stay, days
 Median (Q1–Q3)8(3–16)7(3–15)7(3–15)7(3–15)
Time from last event to the current event, days
 Median (Q1–Q3)NA112(37–366)112(39–297)115(42–287)
Follow-up, months
 Median (Q1–Q3)36(14–36)22(8–33)17(6–27)13(5–23)
  • CBVD, cerebrovascular disease; CHD, coronary heart disease; PAD, peripheral artery disease; Q, quartile.